Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia

Status Completed

Clinical Trial Summary

The objective is to evaluate the clinical effectiveness and safety of PAE in treating patients with BPH.

Clinical Trial Description

Benign prostatic hyperplasia (BPH), non-malignant enlargement of the prostate, is a common condition among elderly men with a prevalence increasing with age. When sufficiently large, the hyperplastic nodules compress the urethral canal to cause obstruction of the urethra and interfere the normal flow of urine, leading to symptoms of urinary hesitancy, frequent urination, increased risk of urinary tract infections and urinary retention. While medication is often prescribed as the first treatment option, it often does not adequately restore normal urine flow. Many patients being treated with medication may not achieve sustained improvement in symptoms, or they may stop taking the medication because of side effects, therefore other forms of treatments may be necessary. Although surgery with transurethral resection of prostate (TURP) is a benchmark for BPH treatment, it involves insertion of an endoscope is inserted through the penis, and removal of the prostate piece by piece. While considered a safe technique with a mortality rate below 0.25%, it is not without adverse events. The most frequent complications are ejaculatory disorders (up to 80%), early urinary incontinence (30 to 40%), acute urinary retention caused by blood clots (2 to 5%), sexual impotence (up to 5%), and the need for blood transfusions (0.4 to 7%). Patients who have undergone TURP require surgical retreatment for lower urinary tract symptoms in 3 to 14.5% of cases. Others include infection and urethral stricture. Therefore TURP is only recommended for complicated or severe BPH due to its adverse effects. Prostatic artery embolization (PAE) is a potentially promising, minimally invasive alternative procedure for BPH. Results from early studies showed that PAE might be a safe and effective treatment for BPH. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02822924
Study type	Interventional
Source	Chinese University of Hong Kong
Contact
Status	Completed
Phase	N/A
Start date	October 7, 2013
Completion date	March 10, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01942551` - Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride	Phase 1
Completed	`NCT01436877` - Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia	N/A
Completed	`NCT02390882` - A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH	Phase 3
Completed	`NCT02839122` - A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects	Phase 1
Not yet recruiting	`NCT01861041` - Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.	Phase 4
Completed	`NCT02332538` - HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH	N/A
Completed	`NCT01835860` - Prostatic Artery Embolization for Benign Prostatic Hyperplasia	Phase 2/Phase 3
Completed	`NCT01665586` - Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study	N/A
Completed	`NCT02038868` - A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia	Phase 2
Completed	`NCT02506465` - Pivotal Study to Assess the Safety and Effectiveness of the iTind Device	N/A
Completed	`NCT01675895` - Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration	Phase 4
Completed	`NCT02483819` - Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients	N/A
Recruiting	`NCT02827578` - Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia	Phase 3
Completed	`NCT02352311` - Safety and Pharmacokinetic Characteristics of DKF-313	Phase 1
Completed	`NCT01494337` - Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP)	Phase 4
Completed	`NCT01627522` - Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate	Phase 2/Phase 3
Completed	`NCT01952912` - Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates	N/A
Active, not recruiting	`NCT01736033` - Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients	Phase 4
Recruiting	`NCT02021032` - Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)	Phase 4
Completed	`NCT00861588` - Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia	N/A